| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S00108-009-2483-Y |
| P698 | PubMed publication ID | 19727633 |
| P2093 | author name string | J R Bogner | |
| R Draenert | |||
| P2860 | cites work | Forthcoming therapeutic perspectives for infections due to multidrug-resistant Gram-positive pathogens. | Q37427876 |
| Doripenem: position in clinical practice | Q37503320 | ||
| Ceftobiprole: a new beta-lactam antibiotic | Q37505285 | ||
| Clostridium difficile infection: current perspectives | Q37541632 | ||
| Ceftobiprole: a new option for treatment of skin and soft-tissue infections due to methicillin-resistant Staphylococcus aureus | Q46787483 | ||
| A randomized, double-blind trial comparing ceftobiprole medocaril with vancomycin plus ceftazidime for the treatment of patients with complicated skin and skin-structure infections | Q46787486 | ||
| New trends in Clostridium difficile virulence and pathogenesis | Q34605658 | ||
| A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity | Q34643123 | ||
| Alternatives to vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections | Q36916071 | ||
| Antimicrobial resistance in Europe and its potential impact on empirical therapy. | Q37336838 | ||
| The structural diversity of acidic lipopeptide antibiotics | Q37373526 | ||
| Alternative strategies for Clostridium difficile infection | Q37419836 | ||
| P433 | issue | 10 | |
| P407 | language of work or name | German | Q188 |
| P921 | main subject | antibiotic | Q12187 |
| P304 | page(s) | 1282, 1284-8 | |
| P577 | publication date | 2009-10-01 | |
| P1433 | published in | Die Innere Medizin | Q1194574 |
| P1476 | title | New antibiotics: small or big advances? | |
| P478 | volume | 50 |
Search more.